PT3259599T - Biomarcadores para diagnóstico e prognóstico de distúrbios ectásicos da córnea - Google Patents

Biomarcadores para diagnóstico e prognóstico de distúrbios ectásicos da córnea

Info

Publication number
PT3259599T
PT3259599T PT167051234T PT16705123T PT3259599T PT 3259599 T PT3259599 T PT 3259599T PT 167051234 T PT167051234 T PT 167051234T PT 16705123 T PT16705123 T PT 16705123T PT 3259599 T PT3259599 T PT 3259599T
Authority
PT
Portugal
Prior art keywords
biomarkers
prognosis
diagnosis
corneal ectatic
ectatic disorders
Prior art date
Application number
PT167051234T
Other languages
English (en)
Original Assignee
Servizo Galego De Saude Sergas
Univ Santiago Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servizo Galego De Saude Sergas, Univ Santiago Compostela filed Critical Servizo Galego De Saude Sergas
Publication of PT3259599T publication Critical patent/PT3259599T/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596Molecules with a "CD"-designation not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/16Ophthalmology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT167051234T 2015-02-16 2016-02-16 Biomarcadores para diagnóstico e prognóstico de distúrbios ectásicos da córnea PT3259599T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15382060.0A EP3056906A1 (en) 2015-02-16 2015-02-16 Biomarkers for diagnosis and prognosis of corneal ectasia

Publications (1)

Publication Number Publication Date
PT3259599T true PT3259599T (pt) 2020-01-27

Family

ID=52589323

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167051234T PT3259599T (pt) 2015-02-16 2016-02-16 Biomarcadores para diagnóstico e prognóstico de distúrbios ectásicos da córnea

Country Status (12)

Country Link
US (2) US10914746B2 (pt)
EP (3) EP3056906A1 (pt)
JP (1) JP6904908B2 (pt)
KR (1) KR102495060B1 (pt)
AU (1) AU2016221761A1 (pt)
CA (1) CA2975951C (pt)
DK (1) DK3259599T3 (pt)
ES (1) ES2764456T3 (pt)
MX (2) MX375275B (pt)
PT (1) PT3259599T (pt)
SG (1) SG11201706249RA (pt)
WO (1) WO2016131840A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6707239B1 (ja) * 2019-03-13 2020-06-10 株式会社中京メディカル 円錐角膜判定装置及びプログラム
KR102287259B1 (ko) * 2019-08-27 2021-08-06 주식회사 비쥬웍스 원추 각막 진단 보조 시스템 및 이를 이용하는 방법
CN113009158B (zh) * 2021-04-30 2023-07-25 天津市眼科医院 中高度近视的辅助诊断标记物及其用途
US11406531B1 (en) * 2021-07-24 2022-08-09 Peter S. Hersh Method for the amelioration of ectatic and irregular corneal disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7370969B2 (en) 2004-03-31 2008-05-13 Nidek Co., Ltd. Corneal topography analysis system
GB0601959D0 (en) * 2006-01-31 2006-03-15 King S College London Sepsis test
US20070248970A1 (en) * 2006-03-24 2007-10-25 Eye Birth Defects Research Foundation Compositions and methods for detecting keratoconus
AU2010327321A1 (en) * 2009-12-02 2012-07-12 The University Of Sydney Diagnostic and therapeutic methods for corneal ectasia following refractive surgery, keratoconus or pellucid degeneration
KR20130027281A (ko) * 2011-09-07 2013-03-15 (주)에스엘에스 원추각막 검사 방법 및 키트
WO2013107826A2 (en) * 2012-01-17 2013-07-25 Institut Pasteur Use of cellular biomarkers expression to diagnose sepsis among intensive care patients
WO2014106833A1 (en) * 2013-01-07 2014-07-10 Singapore Health Services Pte Ltd A process for identification of biomarkers for keratoconus progression

Also Published As

Publication number Publication date
US10914746B2 (en) 2021-02-09
AU2016221761A1 (en) 2017-09-28
JP6904908B2 (ja) 2021-07-21
MX2017010516A (es) 2018-06-15
JP2018510651A (ja) 2018-04-19
EP3608675A1 (en) 2020-02-12
KR102495060B1 (ko) 2023-02-02
WO2016131840A1 (en) 2016-08-25
US20210132084A1 (en) 2021-05-06
HK1248810A1 (en) 2018-10-19
KR20170138400A (ko) 2017-12-15
CA2975951A1 (en) 2016-08-25
MX375275B (es) 2025-03-06
EP3056906A1 (en) 2016-08-17
US20180067128A1 (en) 2018-03-08
MX2020006388A (es) 2020-09-17
ES2764456T3 (es) 2020-06-03
SG11201706249RA (en) 2017-08-30
EP3259599A1 (en) 2017-12-27
EP3259599B1 (en) 2019-10-02
DK3259599T3 (da) 2020-01-13
CA2975951C (en) 2023-02-14

Similar Documents

Publication Publication Date Title
EP3232198A4 (en) Biomarker for diagnosis of hepatoma and use thereof
IL246917B (en) Biomarker and early diagnosis methods for Alzheimer's disease
SG10201910479UA (en) Method for diagnosis and prognosis of chronic heart failure
EP3295327A4 (en) Integrated model for failure diagnosis and prognosis
PL3201361T3 (pl) Sposoby ilościowego oznaczania pozakomórkowego DNA
EP3140426A4 (en) Biomarkers and methods for diagnosis of early stage pancreatic ductal adenocarcinoma
EP3152237A4 (en) Methods and compositions for treatment of disorders with follistatin polypeptides
IL254980B (en) Prognostic and diagnostic glycan-based markers for brain damage
EP3092494A4 (en) Biomarkers for dementia and dementia related neurological disorders
IL251204A0 (en) Biomarkers and predictive methods
HUE049518T2 (hu) Készítmények és eljárások a szem megbetegedéseinek kezelésére és diagnosztizálására
EP3201360A4 (en) Methods for assessing risk of developing breast cancer
EP3110976A4 (en) Method of assessing risk of pml
SG11201606106SA (en) Specific biomarker set for non-invasive diagnosis of liver cancer
IL256096B (en) Inhibitor of igfbp3/tmem219 axis and diabetes
EP3284830A4 (en) Biomarker for mental disease
GB201719639D0 (en) Setection of biomarkers
ZA201807635B (en) Host biomarkers for immunodiagnosis and monitoring of tuberculosis disease
SG11201706249RA (en) Biomarkers for diagnosis and prognosis of corneal ectatic disorders
EP3109636A4 (en) Biomarker for parkinson's disease and use therefor
EP3128326A4 (en) Biomarker for diagnosis of aging or amyotrophia
GB201619808D0 (en) Biomarkers for the prognosis and diagnosis of cancer
EP3674405A4 (en) PROCEDURE FOR EVALUATING THE RISK OF LIVER CELL CARCINOMA
EP3172572A4 (en) Biomarkers for assessment of preeclampsia
EP3189161A4 (en) Methods for diagnosis, prognosis and methods of treatment